Prostate Cancer - Results from #27900

Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells - Abstract June 19, 2011

Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer - Abstract June 17, 2011

The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies - Abstract June 17, 2011

Laparoendoscopic single site (LESS) radical prostatectomy: A review of the initial experience - Abstract June 17, 2011

Bipolar technology for transurethral prostatectomy - Abstract June 17, 2011

Developing imaging strategies for castration resistant prostate cancer - Abstract June 17, 2011

Tumour markers in prostate cancer II: Diagnostic and prognostic cellular biomarkers - Abstract June 17, 2011

Dose escalation in prostate cancer using intensity modulated neutron radiotherapy - Abstract June 17, 2011

Penile rehabilitation after prostate cancer treatment: Outcomes and practical algorithm - Abstract June 17, 2011

Testosterone and prostate cancer: What are the risks for middle-aged men? - Abstract June 17, 2011

Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer - Abstract June 17, 2011

Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer. - Abstract June 16, 2011

Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: The relationship between dose-volume histogram parameters and the occurrence rate - Abstract June 16, 2011

Evaluation of polygenic risk scores for predicting breast and prostate cancer risk - Abstract June 16, 2011

Treatment of low-risk prostate cancer with radical hypofractionated accelerated radiotherapy with cytoprotection (HypoARC): An interim analysis of toxicity and efficacy - Abstract June 16, 2011

Tumor markers in prostate cancer I: Blood-based markers - Abstract June 16, 2011

State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer - Abstract June 16, 2011

Benzyldihydroxyoctenone, a novel nonsteroidal antiandrogen, shows differential apoptotic induction in prostate cancer cells in response to their androgen responsiveness - Abstract June 16, 2011

A miRNA expression signature that separates between normal and malignant prostate tissues - Abstract June 16, 2011

Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer - Abstract June 16, 2011

Page 1396 of 1447